4.7 Article

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Medication therapy of high-dose methotrexate: An evidence-based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

Zaiwei Song et al.

Summary: This study aims to establish an evidence-based practice guideline for individualized medication of high-dose methotrexate (HDMTX) therapy. The guideline was developed using a rigorous and multidisciplinary approach, involving systematic reviews and patient questionnaires. It provides comprehensive and practical recommendations for healthcare providers, covering evaluation prior to administration, dosing regimen, therapeutic drug monitoring, leucovorin rescue, and management of toxicities.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Oncology

Off label intravitreal Brolucizumab in treatment of recurrent macular edema due to branch retinal vein occlusion: A case report

Pradeep Kumar Panigrahi

Summary: A 59-year-old female patient presented with gradual vision loss in the right eye. After receiving Brolucizumab treatment, her vision improved and there was no recurrence of macular edema.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2022)

Review Dermatology

Retrospective analysis of off-label medication use at a plastic surgery hospital in China and evidence-based evaluation

Zhi Gao et al.

Summary: This study retrospectively analyzed off-label prescriptions at a plastic surgery hospital in China, identifying 8.52% of prescriptions as off-label, with a focus on dermatology-related medications. Some off-label prescriptions were recommended by guidelines, highlighting the importance of evidence-based prescribing practices.

DERMATOLOGIC THERAPY (2021)

Review Ophthalmology

Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes

Marko M. Popovic et al.

Summary: In the treatment of retinopathy of prematurity, intravitreal injection (IVI) of antivascular endothelial growth factor agents and laser photocoagulation (LPC) have similar regression rates, but eyes receiving IVI are more likely to require additional treatment and longer time. Eyes receiving IVI required surgical intervention less often compared to LPC, and had lower levels of astigmatism.

SURVEY OF OPHTHALMOLOGY (2021)

Review Ophthalmology

Intravitreal anti-vascular endothelial growth factor versus panretinal LASER photocoagulation for proliferative diabetic retinopathy: a systematic review and meta-analysis

William B. Yates et al.

Summary: This meta-analysis of available evidence suggests a potential benefit of anti-VEGF over PRP for early PDR patients, but these benefits need to be balanced against treatment costs and risks of loss to follow-up.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2021)

Review Environmental Sciences

Off-Label Medication: From a Simple Concept to Complex Practical Aspects

Carmen-Maria Rusz et al.

Summary: Off-label use of drugs, the unapproved use of approved drugs, has been a longstanding issue due to unmet clinical needs. It presents challenges for physicians in various therapeutic areas, prompting efforts by regulatory agencies to ensure safe practice. Awareness and further research are being promoted globally to address the indispensable nature of off-label practice.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Medicine, General & Internal

Off-label medication use in rare pediatric diseases in the United States

Albert Fung et al.

Summary: The use of off-label medication in pediatric patients with rare diseases is a significant public health issue, as there is limited data available for this population. Children present unique considerations in clinical trials due to ethical and clinical concerns, which have hindered drug testing. However, various legislative measures have been implemented to address barriers in pediatric drug testing.

INTRACTABLE & RARE DISEASES RESEARCH (2021)

Article

Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series

Debdulal Chakraborty et al.

American Journal of Ophthalmology Case Reports (2021)

Article Ophthalmology

Off-label use of bevacizumab for wet age-related macular degeneration in Europe

Tomas Bro et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)

Editorial Material Multidisciplinary Sciences

Rapid repurposing of drugs for COVID-19

R. Kiplin Guy et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

15 drugs being tested to treat COVID-19 and how they would work

Leah Shaffer

NATURE MEDICINE (2020)

Review Chemistry, Medicinal

An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease

Hsin- Tuan et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Letter Medicine, General & Internal

Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing

Aaron S. Kesselheim et al.

JAMA INTERNAL MEDICINE (2019)

Article Medicine, General & Internal

RoB 2: a revised tool for assessing risk of bias in randomised trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2019)

Article Medicine, General & Internal

A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement

Yaolong Chen et al.

ANNALS OF INTERNAL MEDICINE (2017)

Review Medicine, General & Internal

Corticosteroids for treating optic neuritis

Robin L. Gal et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)

Review Health Care Sciences & Services

Ethical and legal framework and regulation for off-label use: European perspective

Christian Lenk et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2014)

Article Medicine, General & Internal

AGREE II: advancing guideline development, reporting and evaluation in health care

Melissa C. Brouwers et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Editorial Material Medicine, General & Internal

Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals.

Michelle M. Mello et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Editorial Material Medicine, General & Internal

GRADE:: going from evidence to recommendations

Gordon H. Guyatt et al.

BMJ-BRITISH MEDICAL JOURNAL (2008)

Editorial Material Medicine, General & Internal

GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon H. Guyatt et al.

BRITISH MEDICAL JOURNAL (2008)

Article Health Care Sciences & Services

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

Beverley J. Shea et al.

BMC MEDICAL RESEARCH METHODOLOGY (2007)

Review Medicine, General & Internal

Intra-operative mitomycin c for glaucoma surgery

M. Wilkins et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)